REVIEW ON APPLICATION OF IBUPROFEN PEDIATRIC SUSPENSION FOR INCLUSION IN WHO MODEL LIST 2005

Size: px
Start display at page:

Download "REVIEW ON APPLICATION OF IBUPROFEN PEDIATRIC SUSPENSION FOR INCLUSION IN WHO MODEL LIST 2005"

Transcription

1 1 REVIEW ON APPLICATION OF IBUPROFEN PEDIATRIC SUSPENSION FOR INCLUSION IN WHO MODEL LIST 2005 An application has been submitted by the International Ibuprofen Foundation. The application is based on the belief that the evidence is sufficient to include ibuprofen paediatric suspension in the WHO Model Essential Medicines List. The application is based on the fact that ibuprofen is previously included in the model list and formulary as tablets for the treatment of pain, but paediatric ibuprofen suspension for the treatment of pyrexia still lacking. Electronic databases are furnished in support to this application (see annex). Essential medicines are selected with the regard to disease prevalence, evidence on efficacy and safety, and comparative cost-effectiveness. Otherwise, we examine whether ibuprofen is more effective, safer and less costly than paracetamol. Is paracetamol less effective than ibuprofen? According to the table summarising comparative evidence on efficacy, when we take into account only the controlled studies comparing ibuprofen to paracetamol : 14 studies found that the both medicine produced equal temperature decrease in children, ibuprofen seems more effective than paracetamol in 7 studies. Furthermore, in recent systematic review of 22 controlled trials, Wahba H. describe ibuprofen as providing a longer duration of antipyretic effect than paracetamol at 4 hours after intervention, but paracetamol produced a greater body temperature reduction 0.5 hour after the intervention when compared to ibuprofen. As pointed out in the application, symptomatic treatment of fever with rapid onset is often required to avoid any distress or discomfort of dehydration or seizures in child, according to this statement, paracetamol is more effective than ibuprofen because it acts more quickly than ibuprofen and prevent the complications. Is ibuprofen safer than paracetamol? An analysis of the outcome at the large scale follow up programme ( children) the author found that the risk of hospitalisation for gastro-intestinal bleeding, renal failure or anaphylaxis was no greater in children given ibuprofen than in those receiving paracetamol (Lesko S.M. JAMA 1995; 273: , see also Martindale 2002 ; 33 th edition : 43). Is paracetamol more expensive than ibuprofen? On the basis of price indicator WHO/AFRO/EDP/30.2 published by WHO Regional Office for Africa in December 2003, the mean costs treatment calculated on the basis of Defined Daily Dose in tablets of each drug for the three main providers of the African market (International Dispensary Association IDA, ORBI-PHARMA, TRI-MED Limited ) are US $ for ibuprofen, US $ for paracetamol, treatment with paracetamol seems more expensive than ibuprofen at least for tablets. Furthermore, comparing paracetamol in tablets to the syrup formulation, the syrup is (twelve) times more expensive than tablets, that s the reason why the suspension formulation is rarity in African pharmaceutical market, the mothers of babies often crush the tablets. Does ibuprofen present any public health relevance in comparison to paracetamol? In developing countries fever in children is the widespread health problem particularly at the primary health care system. Many consulting room in primary health care in Africa are managed by nurses, female or male, without any medical doctor at ten kilometres around. A Health authorities provide the nurses with standard therapeutic diagram (STD) for advising

2 2 them in symptomatic treatment of the diseases. All the STD are recommending paracetamol, I am afraid the introduction of ibuprofen become a conflicting issue and will complicate the management of fever at the primary health care in Africa. In view of the above, and also regarding the difficulties of managing paediatric formulations in developing countries and specially in African area where stocking and handling of materials are difficult, I recommend that ibuprofen paediatric formulation is not added to the essential medicine list and that paracetamol remain the medicine of choice for treating fever at this time. References: The references for ibuprofen are based mainly on the table summarising comparative evidence on efficacy provided by international ibuprofen foundation (see Annex). Some articles draw special attention: E. Autret, G. Breart, A.P Jonville : Comparative efficacy and tolerance of ibuprofen syrup in children with pyrexia associated with infectious disease and treated with antibiotics. Eur.J.Clin.Pharmacol. 1994, 46 : J. Sidler, B. Frey, K. Baerlocher : A double blind comparison of ibuprofen and paracetamol in juvenile pyrexia. Br. J. Clin. Pract. 1990; 44 (suppl.70) : A. Van Esch, H.A Van Steensel-Moll : Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch. Pediatr. Adolesc. Med 1995; 149 : P.D Walson, G. Galleta, F. Chomilo : Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. AJDC 1992 ; 146: WHO Regional Office for Africa : Afro Essential Medecines, Price Indicator; December 2003 : A11 & A16. J.T Wilson, R.D Brown, G. L Kearns :, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J. Pediatr. 1991; 119 : Algiers 19 December 2004 A. Helali Member of the Expert Committee

3 3 Annex : Table summarising comparative evidence on efficacy of ibuprofen in fever. Amdekar, et al years IBU 7mg /kg APAP 8mg/kg Single Dose Both IBU and APAP produced a significant reduction in temperature and were comparable for rate, degree, and duration of reduction in temperature. Autret, et al France mos.- 5years IBU 7.5 mg/kg q6h for 12hrs. APAP 10 mg /kg q6h for 12 hrs. IBU> APAP in percent temperature reduction at 4h for all subjects IBU = APAP < 39 C, n=74 IBU = APAP > 39 C, n=77 Over 12hrs., IBU = APAP Autret, et al France mos.- 2 years IBU 7.5 mg/kg APAP 10mg/kg ASA 10 mg /kg IBU> APAP, ASA for AUC, mean reduction in temperature IBU > APAP for number on subjects with normal rectal temperature at 4hrs. Child s Comfort : IBU> ASA, APAP at 6hrs. Goldman et al 2004 Literature review Narrative review Ibuprofen was significantly more effective than acetaminophen in reducing fever after a single dose. Ibuprofen was found to be more effective after 6 hours but not after a longer period of time. Studies with multiple doses have also failed to show that one drug is better than the other.

4 4 Heremans, et al. Belgium years IBU 6mg/kg ASA 10mg/kg Single Dose IBU = ASA rate, degree, duration of temperature reduction Joshi, et al mos.- 12 years IBU 7mg/kg APAP 8mg /kg IBU = APAP rate and degree of temperature reduction APAP > IBU at 0.5 hrs. Kandoth, et al Mean age- 4.3 years IBU 7mg/kg ASA 15 mg/kg IBU = ASA Kauffman, et al years IBU 7.5 or 10 mg/kg APAP 10 mg /kg PBO IBU> APAP temperature reduction, duration; IBU 7.5 mg/kg = IBU 10mg / kg Keinänen- Kiukaanniemi, et al Finland 64 3 mos.- 14 years IBU 6mg/kg KETO 0.5 mg/kg KETO 1.0 mg/kg FEN 10 mg/kg NAP 2mg/kg IBU = KETO 1.0 = FEN = NAP > KETO 0.5 maximum decrease in temperature at 4 hrs. Kelley, et al mos.- 11 years IBU 6mg/kg APAP 10 or 15 mg/kg IBU > APAP 4-8 hrs. maximum temperature decrease: IBU = 183 min., APAP = 133 min.

5 5 Khubchandani, et al years IBU 7mg /kg Mefanamic acid 10mg/kg APAP 10 mg/kg Mefanamic acid > APAP, IBU AUC temp-time curve McIntyre and Hull 1996 England Nahata, et al years 56 6mos.- 12 years IBU 20 mg/kg/d APAP 50mg/kg/d in 4 divided doses q6h for up to 3 days IBU 5 mg/kg or 10 mg /kg PBO IBU =APAP mean temperature change, irritability, clinical condition, overall efficacy, palatability IBU 10mg/kg>IBU 5mg/kg>PBO mean temperature, duration of action, maximum temperature reduction, maximum reduction: IBU10=4hrs IBU 5 = 3hrs PBO = 7hrs Pelen, et al France NA 6mos.- 15 years IBU 10 mg/kg Significant reduction in temperature from 15 mins. through 12 hrs.87-88% acceptable, palatable Perrott et al Systematic review Meta-analysis 10 randomised clinical trials IBU (5-10 mg/kg) > PARA (10-15 mg/kg): ibuprofen was a more effective antipyretic at 2,4 and 6hrs post dose Phadke, et al Purssell E 2002 Literature review years SYSTEMATIC REVIEW IBU 20 mg/kg/day in 3 divided doses APAP mg based on age 8 randomised controlled trials IBU = APAP in reducing temperature and overall therapeutic efficacy IBU = PARA post 1hr IBU > PARA at 6 hrs

6 6 Schactel years IBU 10 mg/kg PARA 15 mg/kg IBU = PARA at significantly reducing oral temperature Sidler, et al Switzerland 89 5mos.- 13 years IBU 7 mg /kg or 10mg/kg APAP 10 mg/kg IBU> APAP lower mean temperature and rate of temperature reduction Similä, et al Finland 79 3mos.- 13 years IBU 0.5 mg/kg IBU 6.0 mg/kg INDO 0.5 mg /kg ASA 10 mg /kg APHZ 5mg/kg IBU 6.0 mg/kg = INDO = ASA= APHZ >IBU0.5mg/kg Thoden et al mos.- 11years IBU7.5mg /kg APAP 12.5mg/kg Temperature control attained significantly earlier (110 mins (p<0.003) ) with IBU compared to APAP (154 mins) &lasted significantly longer (p< 0.001) Van Esch, et al Netherlands mos.- 4years IBU 5mg/kg APAP 10mg/kg IBU> APAP temperature reduction in children with a history of febrile seizures Vauzelle Kervrëdan 1997 France mos.- 12 years IBU 10mg/kg APAP 10 mg/kg IBU= APAP time to peak reduction and rate, extent and duration of temperature reduction Vinh HA et al years IBU 10 mg/kg PARA 12.5mg/kg Multi dose The median (range) fever clearance time (hours) was shorter in the ibuprofen group than the paracetamol group (68,4 to 260vs.104, 12 to 404; P= 0.055) as was the area under the temperature time curve above 37 degree C(74,0 to 237 vs.127,0 to 573; P= 0.013) in typhoid fever

7 7 Wahba H 2004 Literature Review Systematic Review 22 papers Ibuprofen provides a longer duration of antipyretic effect than acetaminophen 4 hours after intervention, and the initial temperature decrement lasts longer. Acetaminophen produced a greater body temperature reduction at 0.5 hour after intervention compared with ibuprofen. Walson, et al years IBU 5mg/kg or 10mg/kg APAP 10mg/kg PBO IBU > 10mg/kg> APAP > PBO IBU 10mg/kg>IBU 5mg/kg>APAP> PBO for temp >102.5 F Walson, et al years IBU>PARA and Dipyrone>PARA temperature normalization rates (82 %, & 78 % respectively) acetaminophen group (68 %) P= Walson, et al mos.- 12 years IBU 2.5, 5, 10mg/kg APAP 15 mg/kg q6h IBU 10mg/kg = APAP 15mg/kg>IBU 2.5mg/kg and IBU 5mg/kg mean percent decrease for first dose but were comparable thereafter Wilson, et al Portugal 35 2 mos.- 10 years IBU50-200mgby age APAP 125mg-500mg by age Q8h IBU>APAP extent and duration of reduction in temperature Wilson, et al mos.- 12 years IBU 5mg/kg 10mg/kg APAP 12.5mg/kg PBO IBU10mg/kg > 5mg/kg, APAP >PBO overall antipyretic effect IBU 10mg/kg = IBU 5mg/kg = APAP for onset and maximum antipyresis IBU 10mg/kg > IBU 5mg/kg in children with high temperatures

8 8 Wong et al mos-6years Dipyrone 15mg/kg IBU5mg/kg/10mg/kg APAP 12mg/kg IBU = Dipyrone > APAP for temperature normalisation frequencies (p< 0.04) ie. percentage of febrile children in the test population whose temp was reduced to 37.5 degrees C. APAP = acetaminophen APHZ = aminophenazone ASA = aspirin FEN = fenoprofen IBU= ibubrophen INDO= indomethacin KETO = ketoprofen NAP = naproxen PARA = paracetamol PBO = placebo

An extrapolation framework to specify requirements for drug development in children

An extrapolation framework to specify requirements for drug development in children An framework to specify requirements for drug development in children Martin Posch joint work with Gerald Hlavin Franz König Christoph Male Peter Bauer Medical University of Vienna Clinical Trials in Small

More information

Evidence synthesis for a single randomized controlled trial and observational data in small populations

Evidence synthesis for a single randomized controlled trial and observational data in small populations Evidence synthesis for a single randomized controlled trial and observational data in small populations Steffen Unkel, Christian Röver and Tim Friede Department of Medical Statistics University Medical

More information

CTP-656 Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies

CTP-656 Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies 39 th European Cystic Fibrosis Conference 8-11 June 2016, Basel, Switzerland 2014 Concert Pharmaceuticals,

More information

THE DEVELOPMENT OF LC GENERlC ANALYTICAL METHODS TO FIGHT COUNTERFEIT NSAIDS USING DESIGN SPACE OPTIMISATI0N STRATEGY

THE DEVELOPMENT OF LC GENERlC ANALYTICAL METHODS TO FIGHT COUNTERFEIT NSAIDS USING DESIGN SPACE OPTIMISATI0N STRATEGY UNIVERSITY of LIEGE THE DEVELOPMENT OF LC GENERlC ANALYTICAL METHODS TO FIGHT COUNTERFEIT NSAIDS USING DESIGN SPACE OPTIMISATI0N STRATEGY J. Mbinze Kindenge, P. Lebrun, B. Debrus, A. Dispas, R.D. Marini,

More information

Use of frequentist and Bayesian approaches for extrapolating from adult efficacy data to design and interpret confirmatory trials in children

Use of frequentist and Bayesian approaches for extrapolating from adult efficacy data to design and interpret confirmatory trials in children Use of frequentist and Bayesian approaches for extrapolating from adult efficacy data to design and interpret confirmatory trials in children Lisa Hampson, Franz Koenig and Martin Posch Department of Mathematics

More information

Experiment 8 Synthesis of Aspirin

Experiment 8 Synthesis of Aspirin Experiment 8 Synthesis of Aspirin Background Aspirin, which ranks as the most widely used drug in the United States, is one of a series of salicylic acid esters that has been known since antiquity to have

More information

A Clinical Trial Simulation System, Its Applications, and Future Challenges. Peter Westfall, Texas Tech University Kuenhi Tsai, Merck Research Lab

A Clinical Trial Simulation System, Its Applications, and Future Challenges. Peter Westfall, Texas Tech University Kuenhi Tsai, Merck Research Lab A Clinical Trial Simulation System, Its Applications, and Future Challenges Peter Westfall, Texas Tech University Kuenhi Tsai, Merck Research Lab Acknowledgement Major collaborators Stephan Ogenstand,

More information

EXPERIMENT 12 UV/VIS Spectroscopy and Spectrophotometry: Spectrophotometric Analysis of a Commercial Aspirin Tablet

EXPERIMENT 12 UV/VIS Spectroscopy and Spectrophotometry: Spectrophotometric Analysis of a Commercial Aspirin Tablet EXPERIMENT 12 UV/VIS Spectroscopy and Spectrophotometry: Spectrophotometric Analysis of a Commercial Aspirin Tablet utcomes After completing this experiment, the student should be able to: 1. Prepare standard

More information

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Page 1 of 7 Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Learning Objectives: Study the dissolution rate (how quickly the compound dissolves) of common OTC (over the

More information

Experiment: Synthesis of Aspirin

Experiment: Synthesis of Aspirin Experiment: Synthesis of Aspirin Background Aspirin, which ranks as the most widely used drug in the United States, is one of a series of salicylic acid esters that has been known since antiquity to have

More information

STUDY OF THE APPLICABILTY OF CONTENT UNIFORMITY AND DISSOLUTION VARIATION TEST ON ROPINIROLE HYDROCHLORIDE TABLETS

STUDY OF THE APPLICABILTY OF CONTENT UNIFORMITY AND DISSOLUTION VARIATION TEST ON ROPINIROLE HYDROCHLORIDE TABLETS & STUDY OF THE APPLICABILTY OF CONTENT UNIFORMITY AND DISSOLUTION VARIATION TEST ON ROPINIROLE HYDROCHLORIDE TABLETS Edina Vranić¹*, Alija Uzunović² ¹ Department of Pharmaceutical Technology, Faculty of

More information

Primary Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis A Detailed Overview Pharmascroll A Pharmascroll Publication This publication is meant to be used only for Pharmascroll clients post subscription. Table of Contents

More information

MoveDMD: Phase 1/2 Trial of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy

MoveDMD: Phase 1/2 Trial of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy MoveDMD: Phase 1/2 Trial of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy Richard Finkel, MD 1, ; Krista Vandenborne, PT, PhD. 2, H Lee Sweeney, PhD. 2,

More information

SI Units. 0 Committee on Drugs

SI Units. 0 Committee on Drugs Committee on Drugs SI Units Le Systeme International d Unites or SI units is a system of measure that is an outgrowth of the metric system, widely used in countries other than the United States. This system

More information

Childhood Nephrotic Syndrome

Childhood Nephrotic Syndrome WORKSH EETS Childhood Nephrotic Syndrome Developed by Pediatric Nephrology Program British Columbia Children s Hospital British Columbia Provincial Renal Agency Vancouver, British Columbia, Canada RD EDITION

More information

Grouping and Annual Reporting. Agenda. Grouping of extension and other variations

Grouping and Annual Reporting. Agenda. Grouping of extension and other variations Grouping and Annual Reporting Zahra Hanaizi Scientific Administrator Safety & Efficacy of Medicines 1 Agenda Grouping of type IA & Periodic Report Rules and examples Procedural aspects Grouping of extension

More information

PK-QT analysis of bedaquiline : Bedaquiline appears to antagonize its main metabolite s QTcF interval prolonging effect

PK-QT analysis of bedaquiline : Bedaquiline appears to antagonize its main metabolite s QTcF interval prolonging effect PK-QT analysis of bedaquiline : Bedaquiline appears to antagonize its main metabolite s QTcF interval prolonging effect Lénaïg Tanneau 1, Elin Svensson 1,2, Stefaan Rossenu 3, Mats Karlsson 1 1 Department

More information

Compare Predicted Counts between Groups of Zero Truncated Poisson Regression Model based on Recycled Predictions Method

Compare Predicted Counts between Groups of Zero Truncated Poisson Regression Model based on Recycled Predictions Method Compare Predicted Counts between Groups of Zero Truncated Poisson Regression Model based on Recycled Predictions Method Yan Wang 1, Michael Ong 2, Honghu Liu 1,2,3 1 Department of Biostatistics, UCLA School

More information

MODULE 1: MATH BASICS

MODULE 1: MATH BASICS MATH FUNDAMENTALS MODULE 1: MATH BASICS In the medical world, the most beneficial drug can be rendered worthless or dangerous if the veterinarian or animal health technician does not accurately calculate

More information

Practical issues related to the use of biomarkers in a seamless Phase II/III design

Practical issues related to the use of biomarkers in a seamless Phase II/III design Practical issues related to the use of biomarkers in a seamless Phase II/III design Tomasz Burzykowski International Drug Development Institute Louvain-la-Neuve, Belgium tomasz.burzykowski@iddi.be www.iddi.com

More information

Linkage Methods for Environment and Health Analysis General Guidelines

Linkage Methods for Environment and Health Analysis General Guidelines Health and Environment Analysis for Decision-making Linkage Analysis and Monitoring Project WORLD HEALTH ORGANIZATION PUBLICATIONS Linkage Methods for Environment and Health Analysis General Guidelines

More information

DIAGNOSTICS NO TOUCH FOREHEAD THERMOMETER

DIAGNOSTICS NO TOUCH FOREHEAD THERMOMETER DIAGNOSTICS NO TOUCH FOREHEAD THERMOMETER nu-beca NO TOUCH THERMOMETER : Thank you for purchasing the nu-beca No Touch Forehead Thermometer. Please read this instruction manual first so you can use this

More information

Two-sample inference: Continuous Data

Two-sample inference: Continuous Data Two-sample inference: Continuous Data November 5 Diarrhea Diarrhea is a major health problem for babies, especially in underdeveloped countries Diarrhea leads to dehydration, which results in millions

More information

CROSS SECTIONAL STUDY & SAMPLING METHOD

CROSS SECTIONAL STUDY & SAMPLING METHOD CROSS SECTIONAL STUDY & SAMPLING METHOD Prof. Dr. Zaleha Md. Isa, BSc(Hons) Clin. Biochemistry; PhD (Public Health), Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia

More information

Body Size is the most important quantitative determinant of drug dose

Body Size is the most important quantitative determinant of drug dose 1 2 Babies, Children, Adults Are All One Species Integrated Rational Dosing Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland Body Size is the most important quantitative determinant

More information

Comparative Chromatographic and Spectrophotometric Methods for Quantitative Estimation of Paracetamol in Analgesic Tablet Dosage Forms

Comparative Chromatographic and Spectrophotometric Methods for Quantitative Estimation of Paracetamol in Analgesic Tablet Dosage Forms Science Journal of Analytical Chemistry 2017; 5(6): 98-103 http://www.sciencepublishinggroup.com/j/sjac doi: 10.11648/j.sjac.20170506.12 ISSN: 2376-8045 (Print); ISSN: 2376-8053 (Online) Comparative Chromatographic

More information

Analysis of Longitudinal Data. Patrick J. Heagerty PhD Department of Biostatistics University of Washington

Analysis of Longitudinal Data. Patrick J. Heagerty PhD Department of Biostatistics University of Washington Analysis of Longitudinal Data Patrick J Heagerty PhD Department of Biostatistics University of Washington Auckland 8 Session One Outline Examples of longitudinal data Scientific motivation Opportunities

More information

Phase I design for locating schedule-specific maximum tolerated doses

Phase I design for locating schedule-specific maximum tolerated doses Phase I design for locating schedule-specific maximum tolerated doses Nolan A. Wages, Ph.D. University of Virginia Division of Translational Research & Applied Statistics Department of Public Health Sciences

More information

Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis A Detailed Overview Pharmascroll A Pharmascroll Publication This publication is meant to be used only for Pharmascroll clients post subscription. Table of Contents

More information

Guidance for Industry

Guidance for Industry Guidance for Industry M4: Organization of the CTD U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

NOTE BY THE TECHNICAL SECRETARIAT ESTABLISHMENT OF A DATABASE OF EXPERTISE ON PEACEFUL USES OF CHEMISTRY

NOTE BY THE TECHNICAL SECRETARIAT ESTABLISHMENT OF A DATABASE OF EXPERTISE ON PEACEFUL USES OF CHEMISTRY OPCW Technical Secretariat 30 August 2016 ENGLISH only NOTE BY THE TECHNICAL SECRETARIAT ESTABLISHMENT OF A DATABASE OF EXPERTISE ON PEACEFUL USES OF CHEMISTRY 1. At its Sixteenth Session, the Conference

More information

RP-HPLC METHOD DEVELOPMENT, VALIDATION FOR QUANTIFICATION OF PARACETAMOL AND IBUPROFEN AND ITS RELATED IMPURITIES IN SOLID DOSAGE FORM

RP-HPLC METHOD DEVELOPMENT, VALIDATION FOR QUANTIFICATION OF PARACETAMOL AND IBUPROFEN AND ITS RELATED IMPURITIES IN SOLID DOSAGE FORM Original Research Article Analytical Chemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 RP-HPLC METHOD DEVELOPMENT, VALIDATION FOR QUANTIFICATION OF PARACETAMOL AND IBUPROFEN AND

More information

Pharmaceutical Calculations Chapters

Pharmaceutical Calculations Chapters Pharmaceutical Calculations Chapters 2013-2014 (1434-1435): Chapters: 1, 2, 3, 4, 6, 7, 8,10,11,12, 13, 15, 16, 17, 21 and 22 Fundamentals of Pharmaceutical Calculations Chapter 1 Dr. Hibah Aldawsari Pharmaceutics

More information

Study No: Title : Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Statistical Methods:

Study No: Title : Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Statistical Methods: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin)

Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin) dx.doi.org/10.14227/dt110204p6 Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin) and Phosphate Standard Buffer ph 6.8, TS of the International Pharmacopoeia with Respect

More information

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC TOTAL AVG

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC TOTAL AVG Jennifer Road Detention Center CY-2016 Health Services Report JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC TOTAL AVG Average Daily Census 421 439 441 399 408 409 421 432 440 425 469 388 5092 CLINIC

More information

City University of Hong Kong

City University of Hong Kong City University of Hong Kong Information on a Course offered by the Department of Physics and Materials Science with effect from Semester A in 2013 / 2014 Part I Course Title: Radiological Physics and

More information

2015 ESMO Translational Research Fellowship Report

2015 ESMO Translational Research Fellowship Report 2015 ESMO Translational Research Fellowship Report Evaluation of c-met expression and inhibition in squamous cell carcinoma of the head and neck Petr Szturz University Hospital Brno, Czech Republic This

More information

MOHAWK COLLEGE OF APPLIED ARTS AND TECHNOLOGY CHEMICAL AND ENVIRONMENTAL TECHNOLOGY DEPARTMENT. Lab Report ROOM NO: FE E309

MOHAWK COLLEGE OF APPLIED ARTS AND TECHNOLOGY CHEMICAL AND ENVIRONMENTAL TECHNOLOGY DEPARTMENT. Lab Report ROOM NO: FE E309 MOHAWK COLLEGE OF APPLIED ARTS AND TECHNOLOGY CHEMICAL AND ENVIRONMENTAL TECHNOLOGY DEPARTMENT Lab Report ROOM NO: FE E309 EXPERIMENT NO : 10 TITLE : Synthesis of Acetylsalicylic Acid Submitted by Class

More information

Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models

Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University July 31, 2018

More information

Spectrophotometric determination of acetaminophen content of different brands of paracetamol tablets from Zliten

Spectrophotometric determination of acetaminophen content of different brands of paracetamol tablets from Zliten Spectrophotometric determination of acetaminophen content of different brands of paracetamol tablets from Zliten Ali Alhalib Department of Chemistry, Faculty of Science, Alasmarya Islamic University, Zliten-Libya

More information

This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform

This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements

More information

Validated Method for the Simultaneous Estimation of Orphenadrine Citrate and Paracetamol in Tablets by Simultaneous Equation Method

Validated Method for the Simultaneous Estimation of Orphenadrine Citrate and Paracetamol in Tablets by Simultaneous Equation Method International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.07, pp 45-55, 2018 Validated Method for the Simultaneous Estimation of Orphenadrine Citrate

More information

This document is a preview generated by EVS

This document is a preview generated by EVS TECHNICAL SPECIFICATION SPÉCIFICATION TECHNIQUE TECHNISCHE SPEZIFIKATION CEN ISO/TS 15883-5 November 2005 ICS 11.080.10 English Version Washer-disinfectors - Part 5: Test soils and methods for demonstrating

More information

Appendix A: Solution Algorithm

Appendix A: Solution Algorithm Appendix A: Solution Algorithm The utility can be decomposed into average ( jt ), idiosyncratic ( ijt ), and random elements (" ijt ): where: U ijt = jt + ijt + " ijt ; jt = p jt + x jt + (A nc jt ) ;

More information

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Page 1 of 8 Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Learning Objectives: Study the dissolution rate (how quickly the compound dissolves) of common OTC (over the

More information

RP - HPLC METHOD FOR ESTIMATION OF PARACETAMOL FROM PHARMACEUTICAL FORMULATION FEBRINIL

RP - HPLC METHOD FOR ESTIMATION OF PARACETAMOL FROM PHARMACEUTICAL FORMULATION FEBRINIL Sci. Revs. Chem. Commun.: 2(3), 2012, 232-236 ISSN 2277-2669 RP - HPLC METHOD FOR ESTIMATION OF PARACETAMOL FROM PHARMACEUTICAL FORMULATION FEBRINIL P. R. SOLANKI, S. PRACHI a and S. D. BOOB b Department

More information

CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus

CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus CHAPTER 3 Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais Sanusi Datuk Dr Aizai Azan Abdul Rahim Dr Ashari

More information

The Impact of CER on Health and Health Care Spending. Tomas J. Philipson, Ph.D Daniel Levin Chair of Public Policy The University of Chicago

The Impact of CER on Health and Health Care Spending. Tomas J. Philipson, Ph.D Daniel Levin Chair of Public Policy The University of Chicago The Impact of CER on Health and Health Care Spending Tomas J. Philipson, Ph.D Daniel Levin Chair of Public Policy The University of Chicago 1 The long history of public technology assessments R.I.P. 1972

More information

Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial

Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial William R. Gillespie Pharsight Corporation Cary, North Carolina, USA PAGE 2003 Verona,

More information

Distributed analysis in multi-center studies

Distributed analysis in multi-center studies Distributed analysis in multi-center studies Sharing of individual-level data across health plans or healthcare delivery systems continues to be challenging due to concerns about loss of patient privacy,

More information

Risk Assessment of Staphylococcus aureus and Clostridium perfringens in ready to eat Egg Products

Risk Assessment of Staphylococcus aureus and Clostridium perfringens in ready to eat Egg Products Risk Assessment of Staphylococcus aureus and Clostridium perfringens in ready to eat Egg Products Introduction Egg products refer to products made by adding other types of food or food additives to eggs

More information

Comparing p s Dr. Don Edwards notes (slightly edited and augmented) The Odds for Success

Comparing p s Dr. Don Edwards notes (slightly edited and augmented) The Odds for Success Comparing p s Dr. Don Edwards notes (slightly edited and augmented) The Odds for Success When the experiment consists of a series of n independent trials, and each trial may end in either success or failure,

More information

al steps utilized well as tables

al steps utilized well as tables Global malaria mortality between 1980 and 2010: a systematic analysis WEBAPPENDIX Authors: Christopher J L Murray, Lisa C Rosenfeld, Stephen S Lim, Kathryn G Andrews, Kyle J Foreman, Diana Haring, Nancy

More information

Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D

Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D University of Jordan Faculty of Pharmacy Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D USP Dissolution Method for PARACETAMOL 500 mg

More information

Mean Kinetic Temperature

Mean Kinetic Temperature Mean Kinetic Temperature History, Math, and Applications Paul Daniel Sr. Regulatory Compliance Expert paul.daniel@vaisala.com Practical Webinar Stuff Challenges with your audio connection? Try calling

More information

Proposal Submission Data Quarterly Report Published: July Proposals by Sponsor Type

Proposal Submission Data Quarterly Report Published: July Proposals by Sponsor Type Proposals by Sponsor Type Sponsors Federal 154 280 251 212 897 168 330 229 211 938 196 289 268 154 907 DHHS 45 114 111 108 378 57 122 114 97 390 62 103 109 87 361 NSF 63 108 96 43 310 67 162 73 47 349

More information

Karen C. Timberlake William Timberlake Fourth Edition

Karen C. Timberlake William Timberlake Fourth Edition Basic Chemistry Karen C. Timberlake William Timberlake Fourth Edition Pearson Education Limited Edinburgh Gate Harlow Essex CM20 2JE England and Associated Companies throughout the world Visit us on the

More information

Modular Program Report

Modular Program Report Modular Program Report The following report(s) provides findings from an FDA initiated query using its Mini Sentinel pilot. While Mini Sentinel queries may be undertaken to assess potential medical product

More information

Modeling & Simulation to Improve the Design of Clinical Trials

Modeling & Simulation to Improve the Design of Clinical Trials Modeling & Simulation to Improve the Design of Clinical Trials Gary L. Rosner Oncology Biostatistics and Bioinformatics The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Joint work with Lorenzo

More information

UV SPECTROPHOTOMETRIC ANALYSIS FOR THE DETERMINATION OF MEFENAMIC ACID IN PHARMACEUTICAL FORMULATION

UV SPECTROPHOTOMETRIC ANALYSIS FOR THE DETERMINATION OF MEFENAMIC ACID IN PHARMACEUTICAL FORMULATION Page3643 Indo American Journal of Pharmaceutical Research, 2015 ISSN NO: 2231-6876 UV SPECTROPHOTOMETRIC ANALYSIS FOR THE DETERMINATION OF MEFENAMIC ACID IN PHARMACEUTICAL FORMULATION Bhagyashree R. Dhumal

More information

A broad spectrum vaccine to prevent invasive Salmonella Infections for sub- Saharan Africa

A broad spectrum vaccine to prevent invasive Salmonella Infections for sub- Saharan Africa A broad spectrum vaccine to prevent invasive Salmonella Infections for sub- Saharan Africa Myron M Levine, Raphael Simon, Sharon Tennant, James Galen, Andrew Lees, Velupillai Puvanesarajah, Ellen Higginson,

More information

Randomized dose-escalation design for drug combination cancer trials with immunotherapy

Randomized dose-escalation design for drug combination cancer trials with immunotherapy Randomized dose-escalation design for drug combination cancer trials with immunotherapy Pavel Mozgunov, Thomas Jaki, Xavier Paoletti Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics

More information

CASE REPORT FORM (April 2012)

CASE REPORT FORM (April 2012) CASE REPORT FORM (April 2012) Surveillance of Paediatric Dengue National Paediatric Hospital, Phnom Penh Kingdom of Cambodia Study contact: I am confident that the information supplied in this case record

More information

Substantiation of Disease and Health-Related Claims in Advertising. Washington, D.C.

Substantiation of Disease and Health-Related Claims in Advertising. Washington, D.C. Substantiation of Disease and Health-Related Claims in Advertising Food, Drug, and Law Institute Food Advertising, Labeling, and Litigation Conference September 13-14, 2017 Washington, D.C. Richard L.

More information

Generalizing the MCPMod methodology beyond normal, independent data

Generalizing the MCPMod methodology beyond normal, independent data Generalizing the MCPMod methodology beyond normal, independent data José Pinheiro Joint work with Frank Bretz and Björn Bornkamp Novartis AG ASA NJ Chapter 35 th Annual Spring Symposium June 06, 2014 Outline

More information

Research Article RP-HPLC Method Development and Validation for Simultaneous Estimation of Clarithromycin and Paracetamol

Research Article RP-HPLC Method Development and Validation for Simultaneous Estimation of Clarithromycin and Paracetamol ISRN Analytical Chemistry Volume 2013, Article ID 948547, 5 pages http://dx.doi.org/10.1155/2013/948547 Research Article RP-PLC Method Development and Validation for Simultaneous Estimation of Clarithromycin

More information

COMMISSION ON ACCREDITATION 2017 ANNUAL REPORT ONLINE

COMMISSION ON ACCREDITATION 2017 ANNUAL REPORT ONLINE COMMISSION ON ACCREDITATION 2017 ANNUAL REPORT ONLINE SUMMARY DATA: DOCTORAL PROGRAMS ^Table titles are hyperlinks to the tables within this document INTRODUCTION The Annual Report was created in 1998

More information

EXAMINATIONS OF THE HONG KONG STATISTICAL SOCIETY HIGHER CERTIFICATE IN STATISTICS, Paper III : Statistical Applications and Practice

EXAMINATIONS OF THE HONG KONG STATISTICAL SOCIETY HIGHER CERTIFICATE IN STATISTICS, Paper III : Statistical Applications and Practice EXAMINATIONS OF THE HONG KONG STATISTICAL SOCIETY HIGHER CERTIFICATE IN STATISTICS, 2002 Paper III Statistical Applications and Practice Time Allowed Three Hours Candidates should answer FIVE questions.

More information

Guideline on adjustment for baseline covariates in clinical trials

Guideline on adjustment for baseline covariates in clinical trials 26 February 2015 EMA/CHMP/295050/2013 Committee for Medicinal Products for Human Use (CHMP) Guideline on adjustment for baseline covariates in clinical trials Draft Agreed by Biostatistics Working Party

More information

Recent Advances to Improve Chemical Development

Recent Advances to Improve Chemical Development Recent Advances to Improve Chemical Development Agenda Challenges in Today s Pharma Industry Industry Drivers for Change Four Ways to Improve Organic Synthesis Enabling Technology Impact of New Tools on

More information

Chemistry 11 Spring 2012 (practice exam) Examination #1

Chemistry 11 Spring 2012 (practice exam) Examination #1 Chemistry 11 Spring 2012 (practice exam) Examination #1 This exam has 20 multiple choice questions each worth 2 points. The free response section includes: Naming and formula (see old exams to prepare

More information

Generalizing the MCPMod methodology beyond normal, independent data

Generalizing the MCPMod methodology beyond normal, independent data Generalizing the MCPMod methodology beyond normal, independent data José Pinheiro Joint work with Frank Bretz and Björn Bornkamp Novartis AG Trends and Innovations in Clinical Trial Statistics Conference

More information

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination. Module Structure: (15 credits each) Lectures and Assessment: 50% coursework, 50% unseen examination. Module Title Module 1: Bioinformatics and structural biology as applied to drug design MEDC0075 In the

More information

ENHANCEMENTS Lash Boost is only to be used as directed by one person. It is not to be shared with other people.

ENHANCEMENTS Lash Boost is only to be used as directed by one person. It is not to be shared with other people. F R E Q U E N T L Y A S K E D Q U E S T I O N S RODAN + FIELDS ENHANCEMENTS LASH BOOST TM W H A T I S E N H A N C E M E N T S L A S H B O O S T? A nightly eyelash conditioning serum that pairs with any

More information

CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus

CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais Sanusi Datuk

More information

Multicompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1

Multicompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1 Multicompartment Pharmacokinetic Models Objectives To draw schemes and write differential equations for multicompartment models To recognize and use integrated equations to calculate dosage regimens To

More information

The World Bank Health System Performance Reinforcement Project (P156679)

The World Bank Health System Performance Reinforcement Project (P156679) Public Disclosure Authorized AFRICA Cameroon Health, Nutrition & Population Global Practice IBRD/IDA Investment Project Financing FY 2016 Seq No: 3 ARCHIVED on 14-Apr-2017 ISR27518 Implementing Agencies:

More information

CHAPTER 7 SUMMARY AND CONCLUSIONS. constitutes the objective of many a research project in the field of pharmaceutical

CHAPTER 7 SUMMARY AND CONCLUSIONS. constitutes the objective of many a research project in the field of pharmaceutical CHAPTER 7 SUMMARY AND CONCLUSIONS Taste masking and development of palatable dosage forms of bitter drugs constitutes the objective of many a research project in the field of pharmaceutical technology.

More information

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC Int. J. Chem. Sci.: 12(3), 214, 115-122 ISSN 972-768X www.sadgurupublications.com SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC D. MAHABOOB BASHA and K. ANANDA

More information

Bayesian Nonparametric Accelerated Failure Time Models for Analyzing Heterogeneous Treatment Effects

Bayesian Nonparametric Accelerated Failure Time Models for Analyzing Heterogeneous Treatment Effects Bayesian Nonparametric Accelerated Failure Time Models for Analyzing Heterogeneous Treatment Effects Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University September 28,

More information

CHILD SAFETY COUNTRY PROFILE Slovenia

CHILD SAFETY COUNTRY PROFILE Slovenia CHILD SAFETY COUNTRY PROFILE 2012 Slovenia The Child Safety Country Profile 2012 for Slovenia highlights the burden of child and adolescent injury and examines socio-demographic determinants to provide

More information

CHILD SAFETY COUNTRY PROFILE Croatia

CHILD SAFETY COUNTRY PROFILE Croatia CHILD SAFETY COUNTRY PROFILE 2012 Croatia The Child Safety Country Profile 2012 for Croatia highlights the burden of child and adolescent injury and examines socio-demographic determinants to provide a

More information

Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of TB

Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of TB Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of TB Rokeya Tasneen 1, Fabrice Betoudji 1, Véronique Dartois, Tian Yang

More information

Core Courses for Students Who Enrolled Prior to Fall 2018

Core Courses for Students Who Enrolled Prior to Fall 2018 Biostatistics and Applied Data Analysis Students must take one of the following two sequences: Sequence 1 Biostatistics and Data Analysis I (PHP 2507) This course, the first in a year long, two-course

More information

SCHOOL OF MATHEMATICS AND STATISTICS. MAS6062 Bayesian Methods and Clinical Trials

SCHOOL OF MATHEMATICS AND STATISTICS. MAS6062 Bayesian Methods and Clinical Trials Data provided: Tables of distribution functions SCHOOL OF MATHEMATICS AND STATISTICS Bayesian Methods and Clinical Trials Spring Semester 05 06 3 hours Candidates may bring to the examination a calculator

More information

Development and Validation of Analytical Method for Simultaneous Estimation of Paracetamol and Ibuprofen Using UV-Visible Spectroscopy

Development and Validation of Analytical Method for Simultaneous Estimation of Paracetamol and Ibuprofen Using UV-Visible Spectroscopy Human Journals Research Article December 2017 Vol.:11, Issue:1 All rights are reserved by Gaikwad. R et al. Development and Validation of Analytical Method for Simultaneous Estimation of Paracetamol and

More information

PSI Journal Club March 10 th, 2016

PSI Journal Club March 10 th, 2016 PSI Journal Club March 1 th, 1 The analysis of incontinence episodes and other count data in patients with Overactive Bladder (OAB) by Poisson and negative binomial regression Martina R, Kay R, van Maanen

More information

Friday 4 November 2016 Morning

Friday 4 November 2016 Morning Oxford Cambridge and RSA F Friday 4 November 2016 Morning GCSE APPLICATIONS OF MATHEMATICS A382/01 Applications of Mathematics 2 (Foundation Tier) *7232728255* Candidates answer on the Question Paper.

More information

ST3241 Categorical Data Analysis I Two-way Contingency Tables. 2 2 Tables, Relative Risks and Odds Ratios

ST3241 Categorical Data Analysis I Two-way Contingency Tables. 2 2 Tables, Relative Risks and Odds Ratios ST3241 Categorical Data Analysis I Two-way Contingency Tables 2 2 Tables, Relative Risks and Odds Ratios 1 What Is A Contingency Table (p.16) Suppose X and Y are two categorical variables X has I categories

More information

CONTACT DETAILS. Cape Town BIOSTATISTICIANS. Esmé Jordaan Specialist Statistician Tel:

CONTACT DETAILS. Cape Town BIOSTATISTICIANS. Esmé Jordaan Specialist Statistician   Tel: CONTACT DETAILS Cape Town Esmé Jordaan Specialist E-mail: esme.jordaan@mrc.ac.za Tel: +27-21-9380922 Interest areas: Finite Mixture models with a focus on Latent Class Models; Growth mixture modelling

More information

DISCRETE PROBABILITY DISTRIBUTIONS

DISCRETE PROBABILITY DISTRIBUTIONS DISCRETE PROBABILITY DISTRIBUTIONS REVIEW OF KEY CONCEPTS SECTION 41 Random Variable A random variable X is a numerically valued quantity that takes on specific values with different probabilities The

More information

IVIVC Industry Perspective with Illustrative Examples

IVIVC Industry Perspective with Illustrative Examples IVIVC Industry Perspective with Illustrative Examples Presenter: Rong Li Pfizer Inc., Groton, CT rong.li@pfizer.com 86.686.944 IVIVC definition 1 Definition A predictive mathematical treatment describing

More information

Chapter 2: Describing Contingency Tables - I

Chapter 2: Describing Contingency Tables - I : Describing Contingency Tables - I Dipankar Bandyopadhyay Department of Biostatistics, Virginia Commonwealth University BIOS 625: Categorical Data & GLM [Acknowledgements to Tim Hanson and Haitao Chu]

More information

Wayne State University Doctor of Pharmacy Program. Curriculum and Course Prerequisites Classes of 2017, 2018, and 2019

Wayne State University Doctor of Pharmacy Program. Curriculum and Course Prerequisites Classes of 2017, 2018, and 2019 Wayne State University Doctor of Pharmacy Program Curriculum and Course Prerequisites Classes of 2017, 2018, and 2019 Updated July 10, 2014 P1 Standing = Admission to the Doctor of Pharmacy Program. P2

More information

Designs for Clinical Trials

Designs for Clinical Trials Designs for Clinical Trials Chapter 5 Reading Instructions 5.: Introduction 5.: Parallel Group Designs (read) 5.3: Cluster Randomized Designs (less important) 5.4: Crossover Designs (read+copies) 5.5:

More information

A Bayesian decision-theoretic approach to incorporating pre-clinical information into phase I clinical trials

A Bayesian decision-theoretic approach to incorporating pre-clinical information into phase I clinical trials A Bayesian decision-theoretic approach to incorporating pre-clinical information into phase I clinical trials Haiyan Zheng, Lisa V. Hampson Medical and Pharmaceutical Statistics Research Unit Department

More information

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region Table 1: Reported cases for the period January December 2018 (data as of 01 February 2019)

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF CEFIXIME

More information

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD Int. J. Chem. Sci.: 6(3), 2008, 1377-1384 SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD JAYESH V. PATEL, C. N. PATEL, P. U. PATEL a PANKAJ H. PRAJAPATI, I. S.

More information